This study is testing a new medicine called dazodalibep for people with Sjögren's Syndrome (SS). Sjögren's Syndrome is a disease where the body's immune system attacks its own healthy cells, causing dry mouth and eyes. The study will see if dazodalibep helps people who have moderate-to-severe symptoms, which means their symptoms are more serious. It will also check if the medicine is safe and how patients feel when taking it through surveys called Patient Reported Outcomes (PROs). To join, you must have been diagnosed with SS and have a certain score from a test called the ESSDAI. This score shows how active the disease is. You also need to test positive for specific antibodies in your blood.

Do not join if you had major blood clots or certain cancers in the past few years. The study will not include any severe heart conditions either. It's important to know that this study could involve some risks from the new medicine.

• Study involves taking dazodalibep and reporting your condition.
• Check if you meet the health requirements before joining.
• Understand the potential risks and benefits.